Reducing Weight and Diabetes Risk in an Underserved Population (STRIDE)

Completed · Phase 2

Conditions studied: Weight Loss, Diabetes Mellitus, Type 2, Psychotic Disorders

In brief

The purpose of this study is to examine the effectiveness of a lifestyle intervention designed to reduce weight and diabetes risk in a population of individuals with mental illness who are also taking antipsychotic medications. We will examine the effectiveness of the intervention in 1. reducing weight and Body Mass Index; 2. reducing fasting insulin levels and increasing insulin sensitivity; and 3. reducing total cholesterol and LDL cholesterol.

Key facts

Study ID
NCT00790517
Run by
Kaiser Permanente
People needed
200
Starts
2009-06-01
Expected to finish
2014-12-01
Last updated by the study team
2015-03-17

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.